Skip to main content
letter
. 2018 Nov;103(11):e544–e548. doi: 10.3324/haematol.2018.188839

Figure 3.

Figure 3.

Negative impact of genetic alterations on progression-free survival (left) and overall survival (right). (A) Mutations in TP53. (B) Mutations in the Cereblon pathway. (C) More than three mutations (1 mutation/61 kb of DNA).